Mejorar el acceso de los pacientes a los ensayos clínicos sobre el cáncer en todo el país.

Tamra is a woman deeply committed to her faith and from the first moment she learned she had Stage 3 Melanoma, she worried less about how cancer will personally impact her and focused more on how she could use this experience to uplift others on a similar journey.

At Lazarex Cancer Foundation we help identify FDA cancer clinical trial options, and reimburse out of pocket travel expenses for travel to cancer clinical trial treatments. We make lifesaving connections that give hope to patients now, and opportunity for new treatments in the future.

The state of diversity in cancer clinical trials today reflects persistent inequities, with minority racial and ethnic groups being underrepresented. Efforts to improve diversity have faced challenges, including low participation rates among African American and Hispanic American individuals. It is crucial for industry sponsors to prioritize diversity and for Congress to extend mandates to all cancer clinical trials to address this issue effectively.